Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Unity Biotechnology, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q2 2024
- Shares held
- 3.46M
- +98.0K (+2.9%) vs. Q2 2024
- Total value
- $5.09M
- +$548.3K (+12.1%) vs. Q2 2024
- New holders
- 7
- 4 more added
- Sold out
- 7
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $1.68K |
| Q2 2025 | 35 | $987.3K |
| Q1 2025 | 40 | $2.95M |
| Q4 2024 | 37 | $3.10M |
| Q3 2024 | 38 | $5.09M |
| Q2 2024 | 39 | $4.66M |
| Q1 2024 | 40 | $5.87M |
| Q4 2023 | 42 | $8.33M |
| Q3 2023 | 36 | $6.42M |
| Q2 2023 | 40 | $6.87M |
| Q1 2023 | 46 | $5.13M |
| Q4 2022 | 54 | $12.6M |
| Q3 2022 | 72 | $24.1M |
| Q2 2022 | 66 | $5.31M |
| Q1 2022 | 71 | $14.2M |
| Q4 2021 | 72 | $21.3M |
| Q3 2021 | 84 | $42.1M |
| Q2 2021 | 98 | $84.0M |
| Q1 2021 | 92 | $121.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 1,004,817 | $1.48M | 0.57% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 920,013 | $1.35M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 590,770 | $868.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 163,242 | $240.0K | 0.00% | +14,199+9.5% | Added |
| Mayo Clinic | 124,081 | $182.4K | 6.29% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 93,670 | $137.7K | 0.00% | +29,088+45.0% | Added |
| BlackRock, Inc. | 81,174 | $119.3K | 0.00% | +81,174 | New |
| UBS Oconnor LLC | 79,354 | $116.7K | 0.00% | +7,371+10.2% | Added |
| Citadel Advisors LLC | 69,210 | $101.7K | 0.00% | −2,998−4.2% | Reduced |
| Ballentine Partners, LLC | 57,046 | $83.9K | 0.00% | +57,046 | New |
| Founders Fund V Management, LLC | 49,172 | $72.3K | 12.64% | 00.0% | Unchanged |
| Morgan Stanley | 44,691 | $65.7K | 0.00% | −8,517−16.0% | Reduced |
| Cercano Management LLC | 41,238 | $60.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 37,824 | $55.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 25,000 | $36.8K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 24,112 | $35.0K | 0.00% | −500−2.0% | Reduced |
| Northern Trust Corp | 22,549 | $33.1K | 0.00% | 00.0% | Unchanged |
| Endowment Wealth Management, Inc. | 13,495 | $19.8K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 11,463 | $16.8K | 0.00% | −1,600−12.2% | Reduced |
| Tower Research Capital LLC (TRC) | 2,059 | $3.03K | 0.00% | −2,740−57.1% | Reduced |
| Steward Partners Investment Advisory, LLC | 2,000 | $2.94K | 0.00% | −1,500−42.9% | Reduced |
| Glen Eagle Advisors, LLC | 1,104 | $1.62K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 387 | $569 | 0.00% | +387 | New |
| Whittier Trust Co | 360 | $529 | 0.00% | +360 | New |
| JPMorgan Chase & Co | 272 | $400 | 0.00% | −511−65.3% | Reduced |
| Signaturefd, LLC | 200 | $294 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 200 | $294 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 126 | $185 | 0.00% | +1+0.8% | Added |
| Ameritas Investment Partners, Inc. | 100 | $147 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 100 | $147 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 61 | $90 | 0.00% | −43,341−99.9% | Reduced |
| AllSquare Wealth Management LLC | 55 | $81 | 0.00% | 00.0% | Unchanged |
| Jaffetilchin Investment Partners, LLC | 50 | $74 | 0.00% | +50 | New |
| Jones Financial Companies LLLP | 26 | $38 | 0.00% | +26 | New |
| HHM Wealth Advisors, LLC | 25 | $37 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 10 | $15 | 0.00% | +10 | New |
| Royal Bank of Canada | 120 | $0 | 0.00% | −271−69.3% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,837−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,479−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,187−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |